Please Wait.....

Report

Middle East & Africa Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others)

Market Report I 2023-01-24 I 229 Pages I The Insight Partners

Discounted by 30% to 2024-06-30

The MEA malaria treatment market is expected to grow from US$ 51.35 million in 2022 to US$ 63.02 million by 2028. It is estimated to grow at a CAGR of 3.5% from 2022 to 2028.

Increasing Prevalence of Malaria is Fueling the MEA Malaria Treatment Market

According to the World Health Organization (WHO), malaria is an acute febrile illness caused by plasmodium parasites, which spread through the bites of infected female Anopheles mosquitoes. Malaria is caused by five parasite species in humans, and two of these species-Plasmodium falciparum and P. vivax-pose the greatest threat. P. falciparum is the deadliest malarial parasite, and it is the most widespread one on the African continent. The WHO's African region continues to account for a disproportionately high share of the global burden of malaria. In 2020, 95% of the global cases of malaria and 96% of deaths were reported in Africa; ~80% of the total deaths caused by malaria are reported in children below five years of age. Four African countries-Nigeria (31.9%), the Democratic Republic of the Congo (13.2%), the United Republic of Tanzania (4.1%), and Mozambique (3.8%)-accounted for nearly half of all malaria-related deaths reported worldwide. According to the LANCET Regional Health 2020, the burden of malaria is the highest in African countries (95%); P. falciparum is the cause of the brunt of mortality in children younger than 5 (? 77%) across the world, and in African countries, this species accounts for ? 96% of total mortalities caused among children by malaria. The rising prevalence of malaria boosts the MEA malaria treatment market t growth.

MEA Malaria Treatment Market Overview

The MEA malaria treatment market is categorized into the UAE, Saudi Arabia, South Africa, Nigeria, The Democratic Republic of Congo, the United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkino Faso, Kenya, Zambia, and the Rest of MEA. In 2021, Saudi Arabia was the largest market for malaria treatment in the region. In 2020, Saudi Arabia witnessed 3,367 people infected with malaria. Additionally, 3,304 cases of malaria (98%) were recorded among teenagers aged 15 and above. The current elimination or treatment strategies in Saudi Arabia focus mainly on targeting the high-risk areas for sustained preventative measures, including management of infection through rapid confirmed diagnosis and treatment. Individual case follow-up and reactive surveillance with appropriate treatment and vector control and active case detection at borders with screening and treatment. Current malaria treatments are also based on the use of artemisinin-based combinations. In Saudi Arabia, the combination of pyrimethamine/sulfadoxine/artesunate is the first line of treatment for uncomplicated malaria, while lumefantrine/artemether (Coartem) is used as a second option. The treatment for severe malaria rests on the use of quinine or artesunate.

MEA Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

MEA Malaria Treatment Market Segmentation

The MEA malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.

Based on treatment, the MEA malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is further categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.

Based on drug type, the MEA malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.

Based on route of administration, the MEA malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.

Based on distribution channel, the MEA malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on end user, the MEA malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The specialty clinics segment held the largest market share in 2022.

Based on country, the MEA malaria treatment market has been categorized into Saudi Arabia, South Africa, the UAE, Nigeria, The Democratic Republic of Congo, the United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkina Faso, Kenya, Zambia, and the Rest of MEA. Our regional analysis states that Saudi Arabia dominated the market in 2022.

AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, and Zydus Healthcare Ltd are among the leading companies operating in the MEA malaria treatment market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Malaria Treatment Market - By Treatment
1.3.2 MEA Malaria Treatment Market - By Drug Type
1.3.3 MEA Malaria Treatment Market - By Route of Administration
1.3.4 MEA Malaria Treatment Market - By Distribution Channel
1.3.5 MEA Malaria Treatment Market - By End User
1.3.6 MEA Malaria Treatment Market- By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Malaria Treatment Market- Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Malaria Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Malaria
5.1.2 Government and Private Sector's Initiatives to Raise Awareness About Malaria
5.2 Market Restraints
5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Extending Pipeline of New Drugs and Vaccines
5.4 Future Trends
5.4.1 Rapid Diagnostic Tests
5.5 Impact Analysis
6. Malaria Treatment Market- MEA Analysis
6.1 MEA Malaria Treatment Market Revenue Forecast and Analysis
7. MEA Malaria Treatment Market Analysis - By Treatment
7.1 Overview
7.2 MEA Malaria Treatment Market, By Treatment 2021 & 2028 (%)
7.3 Prescription Medications
7.3.1 Overview
7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
7.3.3 Chloroquine Phosphate
7.3.3.1 Overview
7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.4 Artemisinin- based Combination Therapies (ACTs)
7.3.4.1 Overview
7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
7.3.5 Atovaquone-Proguanil
7.3.5.1 Overview
7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
7.3.6.1 Overview
7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
7.3.7 Primaquine Phosphate
7.3.7.1 Overview
7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Vaccines
7.4.1 Overview
7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Diagnostic Tests
7.5.1 Overview
7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8. MEA Malaria Treatment Market Analysis - By Drug Type
8.1 Overview
8.2 MEA Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
8.3 Branded
8.3.1 Overview
8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Generics
8.4.1 Overview
8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)
9. MEA Malaria Treatment Market Analysis - By Route of Administration
9.1 Overview
9.2 MEA Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
9.3 Oral
9.3.1 Overview
9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Parenteral and Intravenous Mode
9.4.1 Overview
9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)
10. MEA Malaria Treatment Market Analysis - By Distribution Channel
10.1 Overview
10.2 MEA Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
10.3 Direct Tender
10.3.1 Overview
10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Retail Pharmacies
10.5.1 Overview
10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Online Pharmacies
10.6.1 Overview
10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. MEA Malaria Treatment Market Analysis - By End User
11.1 Overview
11.2 MEA Malaria Treatment Market, By End User 2021 & 2028 (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Specialty Clinics
11.4.1 Overview
11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Homecare
11.5.1 Overview
11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Others
11.6.1 Overview
11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
12. MEA Malaria Treatment Market - Country Analysis
12.1 Overview
12.1.2 MEA: Malaria Treatment Market, by Country, 2021 & 2028 (%)
12.1.2.1 UAE: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 Overview
12.1.2.1.2 UAE: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3 UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.1.3.1 UAE: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.1.4 UAE: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.1.5 UAE: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.1.6 UAE: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.7 UAE: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2 Saudi Arabia: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 Overview
12.1.2.2.2 Saudi Arabia Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.2.3.1 Saudi Arabia: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.2.4 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.2.5 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.2.6 Saudi Arabia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.7 Saudi Arabia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3 South Africa: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 Overview
12.1.2.3.2 South Africa Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3 South Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.3.3.1 South Africa: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.3.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.3.6 South Africa: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.7 South Africa: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4 Nigeria: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 Overview
12.1.2.4.2 Nigeria: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.3 Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.4.3.1 Nigeria: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.4.4 Nigeria: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.4.5 Nigeria: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.4.6 Nigeria: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.7 Nigeria: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.5 The Democratic Republic of Congo: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.5.1 Overview
12.1.2.5.2 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.3 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.5.3.1 The Democratic Republic of Congo: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.5.4 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.5.5 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.5.6 The Democratic Republic of Congo: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.7 The Democratic Republic of Congo: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.6 United Republic of Tanzania: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.6.1 Overview
12.1.2.6.2 United Republic of Tanzania Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.3 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.6.3.1 United Republic of Tanzania: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.6.4 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.6.5 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.6.6 United Republic of Tanzania: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.7 United Republic of Tanzania: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.7 Mozambique: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.7.1 Overview
12.1.2.7.2 Mozambique: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.7.3 Mozambique: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.7.3.1 Mozambique: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.7.4 Mozambique: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.7.5 Mozambique: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.7.6 Mozambique: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.7.7 Mozambique: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.8 Uganda: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.8.1 Overview
12.1.2.8.2 Uganda Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.8.3 Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.8.3.1 Uganda: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.8.4 Uganda: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.8.5 Uganda: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.8.6 Uganda: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.8.7 Uganda: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.9 Ghana: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.9.1 Overview
12.1.2.9.2 Ghana Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.9.3 Ghana: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.9.3.1 Ghana: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.9.4 Ghana: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.9.5 Ghana: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.9.6 Ghana: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.9.7 Ghana: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.10 Burkina Faso: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.10.1 Overview
12.1.2.10.2 Burkina Faso Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.10.3 Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.10.3.1 Burkina Faso: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.10.4 Burkina Faso: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.10.5 Burkina Faso: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.10.6 Burkina Faso: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.10.7 Burkina Faso: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.11 Kenya: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.11.1 Overview
12.1.2.11.2 Kenya Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.11.3 Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.11.3.1 Kenya: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.11.4 Kenya: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.11.5 Kenya: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.11.6 Kenya: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.11.7 Kenya: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.12 Zambia: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.12.1 Overview
12.1.2.12.2 Zambia Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.12.3 Zambia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.12.3.1 Zambia: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.12.4 Zambia: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.12.5 Zambia: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.12.6 Zambia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.12.7 Zambia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.13 Rest of the MEA: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.13.1 Overview
12.1.2.13.2 Rest of the MEA Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.13.3 Rest of MEA: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
12.1.2.13.3.1 Rest of MEA: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.13.4 Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
12.1.2.13.5 Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
12.1.2.13.6 Rest of MEA: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.13.7 Rest of MEA: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 Zydus Healthcare Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sun Pharmaceutical Industries Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sanofi SA
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GSK Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Cipla Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Viatris Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Lupin Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AdvaCare Pharma USA LLC
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners

LIST OF TABLES

Table 1. MEA Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 3. UAE: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 5. UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 6. UAE: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 7. UAE: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 9. Saudi Arabia: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 11. Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 12. Saudi Arabia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 13. Saudi Arabia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. South Africa Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 15. South Africa: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 16. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 17. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 18. South Africa: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 19. South Africa: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Nigeria Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 21. Nigeria: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 22. Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 23. Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 24. Nigeria: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 25. Nigeria: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 26. The Democratic Republic of Congo Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 27. The Democratic Republic of Congo: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 28. The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 29. The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 30. The Democratic Republic of Congo: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 31. The Democratic Republic of Congo: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 32. United Republic of Tanzania Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 33. United Republic of Tanzania: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 34. United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 35. United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 36. United Republic of Tanzania: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 37. United Republic of Tanzania: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 38. Mozambique Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 39. Mozambique: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 40. Mozambique: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 41. Mozambique Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 42. Mozambique: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 43. Mozambique: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 44. Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 45. Uganda: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 46. Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 47. Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 48. Uganda: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 49. Uganda: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 50. Ghana: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 51. Ghana: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 52. Ghana: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 53. Ghana: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 54. Ghana: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 55. Ghana: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 56. Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 57. Burkina Faso: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 58. Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 59. Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 60. Burkina Faso: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 61. Burkina Faso: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 62. Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 63. Kenya: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 64. Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 65. Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 66. Kenya: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 67. Kenya: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 68. Zambia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 69. Zambia: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 70. Zambia: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 71. Zambia: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 72. Zambia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 73. Zambia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 74. Rest of MEA: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
Table 75. Rest of MEA: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 76. Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
Table 77. Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 78. Rest of MEA: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of MEA: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 80. Recent Inorganic Growth Strategies
Table 81. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 82. Glossary of Terms Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Malaria Treatment Market Segmentation
Figure 2. MEA Malaria Treatment Market Segmentation, By Country
Figure 3. MEA Malaria Treatment Market Overview
Figure 4. MEA Malaria Treatment Market, By Distribution Channel
Figure 5. MEA Malaria Treatment Market, By Country
Figure 6. MEA PEST Analysis
Figure 7. MEA Malaria Treatment Market impact analysis of driver and restraints
Figure 8. MEA Malaria Treatment Market - Revenue Forecast and Analysis
Figure 9. MEA Malaria Treatment Market, by Treatment 2021 & 2028 (%)
Figure 10. Prescription Medication: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Chloroquine Phosphate: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Artemisinin- based Combination Therapies (ACTs): MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Atovaquone-Proguanil: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Primaquine Phosphate: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Others: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Vaccines: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Diagnostic Tests: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Others: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. MEA Malaria Treatment Market, by Drug Type 2021 & 2028 (%)
Figure 21. Branded: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Generics: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. MEA Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)
Figure 24. Oral: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Parenteral and Intravenous Mode: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. MEA Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)
Figure 27. Direct Tender: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Hospital Pharmacies: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Retail Pharmacies: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Online Pharmacies: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Others: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. MEA Malaria Treatment Market, by End User 2021 & 2028 (%)
Figure 33. Hospitals: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Specialty Clinics: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Homecare: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Others: MEA Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. MEA Malaria Treatment Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 38. MEA: Malaria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. UAE: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. South Africa: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. Nigeria: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 43. The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 44. United Republic of Tanzania: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 45. Mozambique: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. Uganda: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 47. Ghana: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. Burkina Faso: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 49. Kenya: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 50. Zambia: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 51. Rest of the MEA: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Not Sure / Need Reassuring
- Confirm Content
  - Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
    
    Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
    
    Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
    
    Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
- Sample Pages
  - With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
    
    It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
    
    To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Check for Alternatives
  - Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
    
    To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
Prices / Formats / Delivery
- Prices
  - All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
    
    Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Discounts
  - As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
    
    Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
    
    To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Available Currencies
  - Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
    
    Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
    
    To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
- Licenses
  - License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Global Site License
  - The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
    
    It is important to note that this may exclude Parent Companies or Subsidiaries.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Formats
  - The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
    
    If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
- Delivery
  - Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
    
    Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
    
    If a delay in delivery is expected you will be informed about it immediately.
- Shipping Charges
  - As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
    
    If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
Ordering
- By Credit Card
  - We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
    
    Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
    
    For more information on PayU please visit: https://www.payu.pl/en/about-us
- By Money Transfer
  - If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
    
    With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
Security
- Website security
  - We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
    
    Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
- Credit Card Security
  - We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
    
    PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.